Generate Biomedicines GENB
$9.54 −$0.83 (-8.00%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $9.90 +3.77%
Open$10.06
Prev close$10.37
Day range$9.40 – $10.58
Volume967.9K
Market cap$1.23B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts3
Average target$26.00+172.5% vs. price
- Buy 100%
Low $22.00Now $9.54Avg $26.00High $30.00
Recent rating changes
The last 20 actions on file set price targets from $22.00 to $30.00, averaging $27.70.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 13 Nov 2026 | H.C. Wainwright | BUY | $30.00 |
| 2 Nov 2026 | H.C. Wainwright | BUY | $30.00 |
| 30 Oct 2026 | H.C. Wainwright | BUY | $30.00 |
| 29 Oct 2026 | H.C. Wainwright | BUY | $30.00 |
| 15 Oct 2026 | H.C. Wainwright | BUY | $30.00 |
| 14 Oct 2026 | Piper Sandler | BUY | $26.00 |
| 14 Oct 2026 | H.C. Wainwright | BUY | $30.00 |
| 5 Oct 2026 | H.C. Wainwright | BUY | $30.00 |
| 2 Oct 2026 | Piper Sandler | BUY | $26.00 |
| 9 Sep 2026 | H.C. Wainwright | BUY | $30.00 |
| 8 Sep 2026 | H.C. Wainwright | BUY | $30.00 |
| 28 Aug 2026 | H.C. Wainwright | BUY | $30.00 |
| 17 Aug 2026 | Morgan Stanley | BUY | $22.00 |
| 7 Aug 2026 | Piper Sandler | BUY | $24.00 |
| 7 Aug 2026 | H.C. Wainwright | BUY | $25.00 |
| 24 Jun 2026 | Guggenheim | BUY | $30.00 |
| 15 Jun 2026 | Guggenheim | BUY | $30.00 |
| 14 May 2026 | Morgan Stanley | BUY | $22.00 |
| 8 May 2026 | Piper Sandler | BUY | $24.00 |
| 8 May 2026 | H.C. Wainwright | BUY | $25.00 |
No comments yet — be the first to weigh in on GENB.
Sign in to join the discussion.